Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.515
+0.045 (3.06%)
Aug 27, 2025, 4:00 PM - Market closed
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $355.60 million as of August 27, 2025. Its market cap has decreased by -34.21% in one year.
Market Cap
355.60M
Enterprise Value
488.62M
1-Year Change
-34.21%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $355.60M, a decrease of -93.73%. That is a compound annual growth rate of -31.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 352.60M | 22.13% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
| May 24, 2018 | 5.67B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |